GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 18th Apr 2024 ABUS stock ended at $2.73. This is 1.80% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.72% from a day low at $2.69 to a day high of $2.79.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2024-02-06 $2.36 $2.47 $2.35 $2.47 700 001
2024-02-05 $2.34 $2.42 $2.33 $2.36 1 145 840
2024-02-02 $2.37 $2.39 $2.27 $2.38 1 549 361
2024-02-01 $2.40 $2.41 $2.36 $2.40 462 461
2024-01-31 $2.46 $2.49 $2.37 $2.37 493 118
2024-01-30 $2.54 $2.54 $2.43 $2.46 466 313
2024-01-29 $2.38 $2.55 $2.36 $2.54 3 034 880
2024-01-26 $2.39 $2.42 $2.36 $2.38 556 961
2024-01-25 $2.35 $2.41 $2.33 $2.38 534 919
2024-01-24 $2.44 $2.46 $2.35 $2.35 298 854
2024-01-23 $2.39 $2.41 $2.36 $2.40 315 035
2024-01-22 $2.39 $2.40 $2.33 $2.37 1 008 197
2024-01-19 $2.34 $2.36 $2.29 $2.36 889 516
2024-01-18 $2.29 $2.33 $2.22 $2.32 806 702
2024-01-17 $2.24 $2.27 $2.21 $2.27 317 290
2024-01-16 $2.34 $2.34 $2.24 $2.26 407 854
2024-01-12 $2.40 $2.42 $2.30 $2.31 353 665
2024-01-11 $2.40 $2.40 $2.31 $2.37 514 148
2024-01-10 $2.46 $2.47 $2.40 $2.42 370 316
2024-01-09 $2.41 $2.45 $2.36 $2.43 599 746
2024-01-08 $2.49 $2.57 $2.35 $2.45 1 164 928
2024-01-05 $2.48 $2.51 $2.40 $2.49 560 234
2024-01-04 $2.52 $2.53 $2.46 $2.50 484 979
2024-01-03 $2.60 $2.61 $2.45 $2.50 864 742
2024-01-02 $2.49 $2.63 $2.44 $2.59 1 337 892
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT